Literature DB >> 8648907

Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats.

V Kliem1, R J Johnson, C E Alpers, A Yoshimura, W G Couser, K M Koch, J Floege.   

Abstract

The 5/6 nephrectomy model is used to study pathogenetic mechanisms underlying chronic renal failure. We previously demonstrated that increased mesangial cell proliferation and glomerular PDGF B-chain expression precede glomerulosclerosis in this model. In the present study we have assessed the concomitant changes in the cortical tubulointerstitium. A wave of tubular and interstitial cell proliferation (as determined by immunostaining for PCNA) occurred at week 1 after 5/6 nephrectomy. This wave preceded the peak glomerular cell proliferation by one week. Tubulointerstitial cell proliferation decreased thereafter and reached control values by week 10. In situ hybridization and immunostaining for PDGF B-chain and beta-receptor in sham-operated controls showed labeling of distal tubules and collecting ducts, while no signal was present in the interstitium. PDGF B-chain mRNA and protein expression was markedly increased in tubules at weeks 2 and 4 after 5/6 nephrectomy and in the interstitium (particularly in areas of inflammatory infiltrates) at weeks 2 to 10. Similar changes occurred with PDGF receptor beta-subunit immunostaining. Interstitial expression of desmin and alpha-smooth muscle actin (markers of myofibroblasts) progressively increased after week 1. Interstitial influx of monocytes/macrophages with focal accentuation started at week 2. Counts of lymphocytes, neutrophils and platelets showed only minor changes. In parallel to the monocyte/macrophage influx, progressive interstitial accumulation of collagens I and IV, laminin, and fibronectin occurred. All of these changes were correlated with the increase in serum creatinine, proteinuria and an index of tubulointerstitial damage. We conclude that tubulointerstitial changes after 5/6 nephrectomy show similarities with those observed in the glomeruli. Tubular and interstitial overexpression of PDGF B-chain and its receptor may play a role in mediating fibroblast migration and/or proliferation in areas of tubulointerstitial injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648907     DOI: 10.1038/ki.1996.95

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  48 in total

1.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 3.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

Review 4.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

5.  Long-term evolution of the acute tubular necrosis (ATN) induced by glycerol: role of myofibroblasts and macrophages.

Authors:  Telma J Soares; Roberto S Costa; Rildo A Volpini; Cleonice G A Da Silva; Terezila M Coimbra
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

6.  Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression.

Authors:  B Faria; C Henriques; A C Matos; M R Daha; M Pestana; M Seelen
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

7.  Blocking innate immunity to slow the progression of chronic kidney disease.

Authors:  Christoph Schmaderer; Uwe Heemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-10       Impact factor: 3.000

8.  Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.

Authors:  S Mizuno; T Kurosawa; K Matsumoto; Y Mizuno-Horikawa; M Okamoto; T Nakamura
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

9.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Postnatal renal development of rats from mothers that received increased sodium intake.

Authors:  Ana Paula C Balbi; Roberto S Costa; Terezila M Coimbra
Journal:  Pediatr Nephrol       Date:  2004-08-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.